Advertisement

Index by author

April 01, 2013; Volume 83,Issue 4

  1. Chen, Wen-Shu

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  2. Chen, Yun-Ju

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  3. Christopoulos, Arthur

    1. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
      Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
      Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525

  4. Conn, P. J.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

  5. Cox, Brian

    1. Avram Goldstein: The Founder of Molecular Pharmacology
      Brian Cox, Ji-Sheng Han and Ray Dingledine
      Molecular Pharmacology April 2013, 83 (4) 720-722; DOI: https://doi.org/10.1124/mol.112.084640

  6. Cox, Brian M.

    1. Recent Developments in the Study of Opioid Receptors
      Brian M. Cox
      Molecular Pharmacology April 2013, 83 (4) 723-728; DOI: https://doi.org/10.1124/mol.112.083279

  7. Degregori, James

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  8. Dingledine, Ray

    1. Avram Goldstein: The Founder of Molecular Pharmacology
      Brian Cox, Ji-Sheng Han and Ray Dingledine
      Molecular Pharmacology April 2013, 83 (4) 720-722; DOI: https://doi.org/10.1124/mol.112.084640

  9. Dingledine, Raymond

    1. Ionotropic Glutamate Receptors: Regulation by G-Protein-Coupled Receptors
      Asheebo Rojas and Raymond Dingledine
      Molecular Pharmacology April 2013, 83 (4) 746-752; DOI: https://doi.org/10.1124/mol.112.083352

  10. Duvernay, Matthew

    1. Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
      Matthew Duvernay, Summer Young, David Gailani, Jonathan Schoenecker and Heidi E. Hamm
      Molecular Pharmacology April 2013, 83 (4) 781-792; DOI: https://doi.org/10.1124/mol.112.083477
« Previous (Pages : 1 2 3 4 5 6 7 ... 10) Next »
Back to top

In this issue

Advertisement